Diabetes - Perspectives in Drug Therapy
暫譯: 糖尿病 - 藥物治療的觀點

Schwanstecher, Mathias

Diabetes - Perspectives in Drug Therapy
  • 出版商: Springer
  • 出版日期: 2013-04-21
  • 售價: $15,590
  • 貴賓價: 9.5 折 $14,811
  • 語言: 英文
  • 頁數: 408
  • 裝訂: Quality Paper - also called trade paper
  • ISBN: 3642267424
  • ISBN-13: 9783642267420
  • 相關分類: 化學 Chemistry、生物資訊 Bioinformatics

    • 海外代購書籍(需單獨結帳)

相關主題

商品描述

Preface. Targeting type 2 diabetes. Dual acting and pan-PPAR activators as potential anti-diabetic therapies. GLP-agonists and Dipeptidyl-Peptidase IV Inhibitors. Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes. SGLT Inhibitors as New Therapeutic Tools in the Treatment of Diabetes. Inhibitors of 11b-hydroxysteroid dehydrogenase type 1 in antidiabetic therapy. Nampt and its potential role in inflammation and type 2 diabetes. Inhibition of ganglioside biosynthesis as a novel therapeutic approach in insulin resistance. Overcoming Insulin Resistance with Ciliary Neurotrophic Factor. Thermogenesis and related metabolic targets in anti-diabetic therapy. Interleukin targeted therapy for metabolic syndrome and type 2 diabetes. Fructose-1, 6-Bisphosphatase Inhibitors for Reducing Excessive Endogenous Glucose Production in Type 2 Diabetes. AMP-activated protein kinase and metabolic control. Mitochondria as potential targets in antidiabetic therapy. Research and development of glucokinase activators for diabetes therapy: theoretical and practical aspects

商品描述(中文翻譯)

前言。針對第二型糖尿病的治療。雙重作用及全PPAR活化劑作為潛在的抗糖尿病療法。GLP-激動劑與二肽基肽酶IV抑制劑。大麻素及內源性大麻素在代謝疾病中的角色，重點在糖尿病。SGLT抑制劑作為治療糖尿病的新療法工具。11β-羥類固醇脫氫酶1型抑制劑在抗糖尿病療法中的應用。Nampt及其在炎症和第二型糖尿病中的潛在角色。抑制神經醣脂生物合成作為治療胰島素抵抗的新方法。利用纖毛神經生長因子克服胰島素抵抗。熱產生及相關的代謝靶點在抗糖尿病療法中的應用。針對代謝症候群和第二型糖尿病的白介素靶向療法。果糖-1,6-二磷酸酶抑制劑用於減少第二型糖尿病中過量的內源性葡萄糖產生。AMP活化蛋白激酶及其在代謝控制中的角色。線粒體作為抗糖尿病療法的潛在靶點。糖激酶活化劑在糖尿病療法中的研究與開發：理論與實踐方面。

類似商品